Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Kaire Holdings - $0.50 stock- $3 to $4 Book Value -- Ignore unavailable to you. Want to Upgrade?

To: JP390 who wrote (209)	8/13/1998 10:24:00 PM
From: Michael Graham	Read Replies (1) \| Respond to of 1640

Hey John, how's this: Subject: KAIRE HOLDINGS INC. (KAHI) Date: Tue, 4 Aug 1998 17:42:01 EDT Mime-Version: 1.0 Content-type: text/plain; charset=US-ASCII Content-transfer-encoding: 7bit Kaire Holdings Incorporated (KAHI) Current Price $.052 52 Week High $10.50 52 week low $.05 Outstanding Shares Approx. 8 million Float of shares Approx. 5 million Contact Mr. Benz, Pres 650-340-1074 Based in Los Angeles, Kaire Holdings Incorporated, is a diversified group of companies that collectively provide a range of products and services from non-radioactive medical contrast imaging media and laboratory support services to medical researchers studying human blood flow, to food supplements, anti-oxidants, vitamins, weight management and personal care products to the receptive growing world wide baby boomer market. For More Information visit thier web-site at www.imt-ltd.com. KAHI also owns 1,570,000 shares of Kaire International. Kaire International is set to go public within the next two weeks. These holding will give KAHI an Added book value of .90 cents a share. KAHI is also in the process of mergering with Potomac Chemicals. Here is an Excerpt from the lastest press release. LOS ANGELES--(BUSINESS WIRE)--April 14, 1998--Kaire Holdings Incorporated ("KHI"), BBS trading symbol KAHI, announced today, following its Agreement release on January 27, 1998, that Potomac Chemicals' chairman David Wang will head up the executive management team to determine the terms for a potential acquisition of a direct marketing company in Malaysia. Per David Wang: "It is Potomac's objective to seek distribution outlets where we already have existing licenses as part of our agreement with Kaire Holdings to expand the sale of their products in the Far East. Concurrent with Malaysia Potomac is actively in discussions with several other countries in the Far East. We at Stockwiz have learned that the acquisition with Potamac Chemicals is near completion and the company is expecting several news releases in the next few weeks. We are rating KAHI an aggressive buy up to a share price of .50 cents. Short Term outlook. (3-4 weeks) .75 - .90 Long Term Outlook. (2-4 months) $1.50 - $1.75 Nothing in this E-mail shall constitute a solicitation or an offer to buy or sell any securities herein. All investments should be discussed with a qualified investment professional. All statements made are the express opinion of Stockwiz staff and should be treated as such. Mike Boy, am I good or what!